Armata Pharmaceuticals, Inc.

Industry

  • Biotechnology
    • Large Molecule
  • Pharmaceuticals

Other Names/Subsidiaries

  • C3J Therapeutics
  • C3 Jian
See more in Biomedtracker

Latest on Armata Pharmaceuticals, Inc.

Scrip

Innoviva Aims For Antibiotic Success With La Jolla, Entasis Acquisitions

 
• By Mandy Jackson

Innoviva, Inc. continues to branch out from collecting royalties on inhaled respiratory medicines commercialized by GlaxoSmithKline Pharmaceuticals Ltd. to a company also developing and commerciali

Pink Sheet

Cormedix Leads Limited Pipeline For US FDA’s LPAD Pathway

 
• By Bridget Silverman

CorMedix Inc. is gearing up to try for approval of its catheter lock solution Neutrolin under the US Food and Drug Administration’s Limited Population Pathway for Antibacterial and Antifungal Drugs (

Scrip

Deal Watch: Celgene Makes Alliances With Kyn, Obsidian After Bristol Buyout

 
• By Joseph Haas, Jo Shorthouse, Ian Haydock, John Davis, Brian Yang, and Anju Ghangurde

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Strategic Transactions . Celgene Collaborations Inclu

In Vivo

Execs On The Move, December 2016

 
• By Regina Paleski

Company Changes BISHOP , Kathie M., PhD To: Otonomy Inc. , CSO (November) From: Tioga Pharmaceuticals, CSO Phone: 858-242-5200 BOGATYRENKO , Yulii To: TherapeuticsMD Inc. , SVP, Bus. Dev.